Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00845897 · ClinicalTrials.gov registry record · NA

Botulinum Toxin Effects on Plantar Ulcer Recurrence

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT00845897 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 17 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00845897, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

The purpose of this grant is to collect pilot data to assess the amount of botulinum toxin that needs to be injected into the calf muscles of subjects with diabetes mellitus, peripheral neuropathy, and a plantar ulcer to decrease muscle strength. We hypothesize that a decrease in plantar flexor muscle strength will temporarily decrease plantar pressure. The decrease in plantar pressure will provide temporary protection to the new tissue as it gains tolerance to high stress with the long term potential outcome as a decrease in the ulcer recurrence rate.

Interventions

  • DRUG Saline
  • DRUG Botulinum Toxin

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2005-03
Est. Completion 2010-03
Phase NA

What the Registry Record Tells You About NCT00845897

The ClinicalTrials.gov registry entry for NCT00845897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.

NCT00845897 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00845897 about?

NCT00845897 is a clinical study titled "Botulinum Toxin Effects on Plantar Ulcer Recurrence". The purpose of this grant is to collect pilot data to assess the amount of botulinum toxin that needs to be injected into the calf muscles of subjects with diabetes mellitus, peripheral neuropathy, and a plantar ulcer to decrease muscle strength. We hypothesize that a decrease in plantar flexor musc...

What is the current status of trial NCT00845897?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2005-03. Estimated completion is 2010-03.

What interventions are being tested in trial NCT00845897?

The interventions under investigation include: Saline (DRUG), Botulinum Toxin (DRUG).

Who is sponsoring clinical trial NCT00845897?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.